SUMMARY
SUMMARY

CD4
+ T follicular helper (Tfh) cells provide the required signals to B cells for germinal center reactions that are necessary for long-lived antibody responses. However, it remains unclear whether there are CD4 + memory T cells committed to the Tfh cell lineage after antigen clearance. By using adoptive transfer of antigen-specific memory CD4 + T cell subpopulations in the lymphocytic choriomeningitis virus infection model, we found that there are distinct memory CD4 + T cell populations with commitment to either Tfh-or Th1-cell lineages. Our conclusions are based on gene expression profiles, epigenetic studies, and phenotypic and functional analyses. Our findings indicate that CD4 + memory T cells ''remember'' their previous effector lineage after antigen clearance, being poised to reacquire their lineage-specific effector functions upon antigen reencounter. These findings have important implications for rational vaccine design, where improving the generation and engagement of memory Tfh cells could be used to enhance vaccine-induced protective immunity.
INTRODUCTION
Naive pathogen-specific CD4 + T cells respond to acute infections through robust proliferation and differentiation to generate effector cells with the capacity to provide help to the many and diverse branches of the immune system. Following antigen clearance, the majority of antigen-specific effector cells undergo apoptosis, leaving behind a population of memory CD4 + T cells.
In addition to their ability to survive and undergo homeostatic proliferation in the absence of antigen, memory T cells retain the capacity to rapidly recall effector function, traffic to a wide range of tissues, and exist at much higher frequencies than naive cells specific for the same antigen. These features provide the host with a protective network of pathogen-specific memory T helper cells that are poised to swiftly respond upon a secondary challenge (Sallusto et al., 2010) . Naive CD4 + T cells have multiple fates and upon activation can develop into a variety of specialized subsets, such as T helper 1 (Th1), Th2, Th17, and regulatory T (Treg) cells. Each of these lineages has distinct gene expression programs that are regulated by specific STATS, transcription factors, and epigenetic mechanisms (O'Shea and Paul, 2010) . More recently, an additional subset known as T follicular helper (Tfh) cells has been identified as the CD4 + T cell subset that provides help for antibody responses. Tfh cells provide the necessary signals to antigen-specific B cells to generate and maintain the germinal center reaction, thus facilitating efficient class switching and affinity maturation of antibodies, and the generation of long-lived antibody-secreting plasma cells (Crotty, 2011) . Tfh cells were first characterized in humans by their expression of the B cell follicle homing receptor CXCR5 (Breitfeld et al., 2000; Kim et al., 2001; Schaerli et al., 2000) , high ICOS and PD-1 expression, and the transcription factor Bcl6 . Tfh cells can localize to the B cell follicle by sensing CXCL13 through CXCR5 (Ansel et al., 1999; Kim et al., 2001 ). Bcl6 has recently been identified as a Tfh lineage regulator (Johnston et al., 2009; Nurieva et al., 2009; Yu et al., 2009) , and shares a reciprocal relationship with the transcriptional repressor Blimp-1, which suppresses Tfh differentiation Johnston et al., 2009 ). However, it remains unclear whether Tfh cells possess the capacity to further differentiate into the resting memory CD4 + T cell pool and retain their Tfh lineage commitment after antigen clearance (Crotty, 2011; Fazilleau et al., 2007; Liu et al., 2012; Lü thje et al., 2012; Marshall et al., 2011; Pepper et al., 2011; Weber et al., 2012) .
To address whether Tfh memory cells exist within the pool of memory CD4 + T cells, we studied virus-specific CD4 + T cells throughout the primary, memory, and secondary effector phases of the immune response following acute lymphocytic choriomeningitis virus (LCMV) infection. We report here that a distinct CXCR5 + subset of antigen-specific CD4 + T cells preferentially recalled a Tfh cell secondary response following transfer and Figure 1A ). We observed that approximately 45% of virus-specific effector (day 7 postinfection) SMARTA cells expressed CXCR5 and high amounts of PD-1 and ICOS and contained a subpopulation of GL-7 hi germinal center Tfh cells (Yusuf et al., 2010) , consistent with a Tfh phenotype ( Figure 1B) . Further, the majority of CXCR5 + effector cells downregulated Ly6c expression and expressed low levels of granzyme B, while the CXCR5 À effector cells displayed higher Ly6c and granzyme B expression (Figure 1B) . In addition, CXCR5 + effector SMARTA cells expressed Bcl6 and low amounts of T-bet, whereas CXCR5 À effector cells were Bcl6 negative and expressed high amounts of T-bet (Figure 1C) . Similar to LCMV-specific SMARTA Tg cells, endogenous LCMV GP 66-77 specific (tetramer + ) effector CD4 + T cells in LCMV-infected B6 mice exhibited the same dichotomy of CXCR5 + and CXCR5 À cells with similar expression patterns of PD-1, Ly6c, Bcl6, and T-bet (see Figure S1A and S1B available online). These data demonstrate the generation of both Tfh and Th1 virus-specific effector cells during LCMV infection, which could be generally distinguished by Ly6c and CXCR5 expression. In agreement with this, Ly6c lo SMARTA effector cells localized predominantly within the B cell follicle and germinal centers, whereas Ly6c hi effector cells were generally outside of B cell follicles and germinal centers ( Figure S1F ).
We observed that CXCR5 + Tfh effector cells were lower for Psgl1 expression than CXCR5 À Th1 effector cells ( Figure S1C ).
This finding was consistent with a previous report that showed Bcl6-dependent downregulation of Psgl1 expression on Tfh cells (Poholek et al., 2010) . Another recent study also using the LCMV infection model used the markers Psgl1 and Ly6c in combination to identify effector and memory subsets of LCMV-specific CD4 T cells (Marshall et al., 2011 Figures S1D and S1E ), indicating that the combination of Psgl1 and Ly6c markers is not useful for subsetting cells with the most Tfh-like qualities at both effector and memory time points.
Interestingly, whereas PD-1, ICOS, GL-7, and Bcl6 expression were absent on virus-specific memory cells (day 105), approximately 40% of SMARTA cells maintained CXCR5 expression, albeit at decreased surface expression relative to effector Tfh cells ( Figures 1B and 1C) , a pattern which was also observed in endogenous GP [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] tetramer + memory cells ( Figure S1B ). Antigen-specific CXCR5 + memory cells were also observed in the blood but had reduced Bcl6 expression relative to their effector counterparts ( Figures 1D and 1E ). CXCR5 + effector cells were abundant in blood and secondary lymphoid organs; however, unlike CXCR5 À Th1 effector cells, CXCR5 + cells were almost entirely excluded from nonlymphoid tissues such as lung, liver, and IEL ( Figure 1F ). As expected, the total number of memory SMARTA CD4 + T cells in each tissue was reduced compared to the effector stage (Table S1 ), and coincided with a similar pattern in the tissue distribution of CXCR5 + and CXCR5 À cells at the memory time point ( Figure 1F indicates the number of each subset in spleen following infection (n R 3 at each time point). Error bars represent the SEM. See also Figure S1 and Table S1 . (Figure 2A) . Similarly, many genes that were expressed in Tfh effector cells were also expressed in the CXCR5 + Ly6c lo and CXCR5 + Ly6c int memory subsets, whereas expression of these same genes was downregulated in Th1 effector and memory cells ( Figure 2A ). We performed gene set enrichment analysis (GSEA) of the microarray data sets to further evaluate the degree that gene expression patterns were shared between these various subsets. These analyses revealed that gene expression patterns by CXCR5 Figure S2C ). Together, these data indicate that the gene expression patterns of Cxcr5 and these transcription factors that define the Th1 and Tfh lineages in CD4 + T cells are maintained (although at lower expression amounts compared to effector cells) in subsets of resting memory cells. In addition, we found that gene expression of the transcription factor Plagl1 (Abdollahi, 2007) , a gene with no previously reported role in CD4 + T cell differentiation, distinguished between the Th1 and Tfh cell populations at both the effector and memory phases of the immune response ( Figure 2C ). We next examined the expression of genes that encode cytokine and chemokine receptors, costimulatory and inhibitory receptors, cytokines, and cytotoxic molecules. Expression of Th1-associated genes including Il-2ra, Ifng, Ccl5, and Gzmb were more highly expressed in the CXCR5
À
Ly6c
hi compared to the CXCR5 + Ly6c lo and CXCR5 + Ly6c int memory populations ( Figures 2D and 2E ). In contrast, genes involved in Tfh function and differentiation (Crotty, 2011) , including Cxcr5, Cxcr4, Il6ra, Pdcd1 (PD-1), Cd200, and Sh2d1a (SAP), were more highly expressed in memory CXCR5 + Ly6c lo compared with memory CXCR5
À
Ly6c
hi cells (Figures 2B and 2D-2F; Figure S2D ). Of note, several genes related to the cytotoxic potential of effector cells, including those that code for granzyme B and other granzymes, perforin, and Fas ligand were preferentially increased in the CXCR5 À Ly6c hi SMARTA effector cells ( Figure 2E ). 
hi and CXCR5 + Ly6c lo responding memory populations was relatively similar in the spleen 7 days postinfection (between 62-and 69-fold, assuming a 10% take in the spleen following adoptive transfer), whereas the CXCR5 + Ly6c int subset expanded more extensively (approximately 248-fold) ( Figure 3B Figure S3D ). Importantly, the transfer of CXCR5 + memory experiments for a total of n = 11-14 mice per group. Data in (F) and (G) were from a single experiment (n = 3 per group) and were representative of two to four independent experiments. Statistically significant p values are shown and were determined using a two-tailed unpaired Student's t test. Error bars represent the SEM. See also Figure S3 . significantly increased levels of T-bet expression ( Figure 3G ; Figure S3D ). In addition, the majority of these cells was CXCR5 À and had an enhanced capacity for granzyme B expression in both the spleen ( Figure 3I ; Figure S3A ) and in lung ( Figure S3G ). In contrast, although the majority of effector cells generated from CXCR5 + Ly6c lo and CXCR5 + Ly6c int subsets were CXCR5 + , those that became CXCR5 À cells had a diminished capacity to express granzyme B ( Figure 3I ; Figure S3A ), even in the lung, a nonlymphoid tissue that enriches for Th1 effector cells ( Figure S3G ). To determine whether Th1 and Tfh memory cells maintain their respective lineage biases in the absence of antigen, sorted Th1 memory and Tfh memory SMARTA cells were adoptively transferred into naive recipient mice and rested for 28 days before rechallenging these recipients with acute LCMV infection ( Figure 4A ). Consistent with our previous results (Figure 3 ), CXCR5
+ Tfh memory cells preferentially generated Tfh effector cells ( Figure 4B ) and GL7 + GC Tfh cells ( Figure 4C ). Furthermore, these effector cells expressed significantly more Bcl6 and less T-bet ( Figures 4D and 4E ). The CXCR5 À effector cells that were generated from the CXCR5 + Tfh memory population also had significantly higher ICOS expression ( Figure 4F ) and exhibited an impairment for granzyme B expression compared with those generated from CXCR5 À Th1 memory cells ( Figures   4G and 4H ). After challenge, memory Th1 cells generated Th1 effector cells with high T-bet and granzyme B expression (Figure 4) . Thus, the capacity of CXCR5 À Th1 and CXCR5 + Tfh memory cells to recall their lineage-specific responses is not dependent on the continued presence of antigen during the maintenance phase of memory differentiation.
Cells with a Central Memory Phenotype Exist within the Tfh and Th1 Memory Populations
We next evaluated whether a central memory phenotype (by CD62L and CCR7 expression) was associated with CXCR5 expression by memory cells. As expected, within 5 days post-LCMV infection, SMARTA cells had downregulated CD62L, followed by the gradual re-expression by memory cells (Figure S4A ). Compared to day 8 effector cells that were almost entirely CD62L À and had downregulated CCR7, all memory SMARTA cells expressed some surface CD62L and CCR7, being either low or intermediate for each of these surface markers ( Figure S4B ). Further analysis showed that cells expressing high levels of surface CD62L and CCR7 existed within both CXCR5 + and CXCR5 À memory populations ( Figure S4C ). Thus, cells of a central memory phenotype exist within both Th1 and Tfh memory populations ( Figure S4C ). (Crotty, 2011) . We next evaluated whether memory Tfh cells could recall aspects of the Tfh effector program when reactivated in the absence of B cells by transferring them into B cell deficient recipients prior to LCMV infection ( Figure 5A ). As expected, GL-7 + (germinal center phenotype) Tfh-like effector cells were nearly undetectable in B cell deficient recipient mice following infection ( Figure S5) . Similar to what has been previously reported (Johnston et al., 2009) , naive SMARTA cells transferred into B cell deficient mice generated a significantly reduced frequency of CXCR5 + Tfh-like effector cells at day 7 postinfection, which continued to decrease to less than 10 percent by day 10 ( Figures 5B and  5C each time point following infection with LCMV. Data for day 7 were combined from two independent experiments (n = 7 per experimental group) and day 10 were from one experiment (n = 3 per group). Statistically significant p values were determined using a two-tailed unpaired Student's t test (***p < 0.001; **p < 0.01; *p < 0.05). See also Figure S5 .
and Tfh effector, and Th1 and Tfh memory cells following LCMV infection. We found that the Gzmb locus becomes unmethylated exclusively in Th1 effector cells and remains unmethylated in Th1 memory cells, whereas CD4 + Tfh cells retain the naive DNA methylation program at the Gzmb locus throughout effector and memory differentiation (Figure 6D) . Thus, our data show that methylation of the Gzmb locus can be used to distinguish CD4 + Th1 cells from Tfh cells and further confirm the lineage relationship between effector and memory Tfh cells. Furthermore, the repression of cytotoxic molecule expression such as granzyme B and perforin ( Figure 2E ) in Tfh cells may be essential for preventing the unwanted destruction of antigenpresenting B cells. We also examined the methylation status of several other loci in Th1 and Tfh lineage cells. Surprisingly, the Il21 locus was demethylated in both Tfh and Th1 cells and remained unmethylated in both memory populations (Figure 6E) . Although IL-21 is characterized as a cytokine critical for Tfh function, Th1 cells can also express it, albeit with reduced transcript levels (Figure 2) (Fahey et al., 2011; Spolski and Leonard, 2010) . Similarly, the Ifng locus became demethylated in both Tfh and Th1 cells and remained unmethylated in memory cells (Figure 6E ). These data suggest that both Th1 and Tfh memory CD4 , 2012) . In this study, by using the mouse + T cells to Th1 or Tfh lineages provides cells that are poised for the lineage-specific reexpression of effector molecules upon reexposure to antigen (see model in Figure S6 ).
In contrast to our findings, by using a Listeria monocytogenes infection model, Pepper et al. suggested that memory CD4 + T cells that express CXCR5 and CCR7 are a central memory population with a capacity to fully reconstitute Th1 and Tfh effector populations (Pepper et al., 2011) . Whereas our study also shows that there is more pluripotency among the Tfh compared to Th1 memory population, there is still clear evidence of antigen shows a delayed or impaired ability to express granzyme B. It has been shown that maintenance of repressive DNA methylation programs at the Il4 and Foxp3 loci are essential for preventing aberrant expression of these molecules in non-Th2 and non-Treg CD4 + T cell lineages, respectively (Josefowicz et al., 2009; Makar et al., 2003) . Thus, the maintenance of DNA methylation at the Gzmb locus (and other Th1-specific loci) in Tfh memory cells may reinforce their Tfh lineage commitment by repressing genes used by Th1 lineage cells (Liu et al., 2012) . Another study suggested that rechallenge of memory cells derived from adoptively transferred Tfh effector cells exhibited a Tfh phenotype 2.5 days after reimmunization; however, this phenotype was diminished 6 days postreactivation (Weber et al., 2012) . Morita et al. reported that CXCR5 + CD4 + T cells found in human blood are functional counterparts to Tfh cells found in lymphoid organs and suggest that these may be memory Tfh cells (Morita et al., 2011) . The repression of cytotoxic potential appears to be a hallmark of Tfh cells, and expression of key cytolytic molecules such as granzyme B and perforin was inhibited in Tfh but not Th1 effector cells. Together, these data suggest that Tfh differentiation is coupled to the restriction in cytotoxic potential by preventing expression of Th1 cell-related killing apparatus components. The epigenetic repression of cytotoxic molecules by Tfh cells may be essential to prevent the unwanted destruction of antigen-presenting germinal center B cells, which rely on cell-contact-dependent interactions (including CD40L and SAP) with Tfh cells for essential signals (Cannons et al., 2010; Crotty et al., 2003 , Crotty, 2011 Qi et al., 2008 (Plotkin et al., 2013) . Gaining a better understanding of the development, function, and contribution of Tfh memory cells within the context of prime and boost vaccination and pathogen challenge will provide avenues for rational vaccine design (D'Argenio and Wilson, 2010) . Developing effective vaccines for pathogens such as HIV and malaria will likely require the generation of high-titer broadly neutralizing antibody responses (Burton et al., 2012) . Similarly, efforts to develop universal influenza vaccines by targeting conserved epitopes (Sette and Rappuoli, 2010 ) may possibly be improved by optimally inducing memory Tfh cells. It is likely that vaccine strategies that fail to induce the generation of primary Tfh cells will subsequently leave a gap in the pool of antigen-specific memory CD4 + T cells, resulting in suboptimal boosting of antibody responses. Conversely, immunogens, adjuvants, or strategies that promote robust Tfh responses and drive commitment and maintenance of high numbers of antigen-specific memory Tfh cells may enhance the quality and/or quantity of antibody production following antigen boost or pathogen encounter. Thus, it is critical to design rational prime and boost strategies for optimal generation of Tfh memory cells.
EXPERIMENTAL PROCEDURES
Mice and Adoptive Transfers
Congenically marked (CD45.1) CD4 + T cell splenocytes specific to the GP 66-77 epitope of LCMV obtained from naive SMARTA TCR transgenic mice (Oxenius et al., 1998) were intravenously transferred into naive C57BL/6 (CD45.2) mice (Jackson Laboratory, Bell Harbor, ME were adoptively transferred into naive C57BL/6 mice (CD45.2) or B celldeficient mMT mice that were subsequently infected 24 hr later with 2 3 10 5 PFU of LCMV Armstrong. Animal experiments were conducted in accordance with Emory University IACUC protocols.
FACS Analysis and Sorting
Cells were stained as described previously (Youngblood et al., 2011) with fluorochrome-conjugated antibodies (purchased from BD, eBiosciences, BioLegend, Vector Laboratories, and Invitrogen). A three-step CXCR5 staining was performed as described by Johnston et al. (2009) by using purified rat anti-mouse CXCR5 (BD), a secondary Biotin-SP-conjugated Affinipure F(Ab') 2 Goat anti-rat IgG (Jackson Immunoresearch) and finally with streptavidin-APC or streptavidin-PeCy7 (Invitrogen). For Bcl6 and T-bet staining, cells were first stained for surface antigens, followed by permeabilization, fixation, and staining by using the Foxp3 Permeabilization/Fixation Kit and protocol (eBioscience). Intracellular cytokine staining was done by standard techniques following 5 hr stimulation with GP 61-80 peptide (MuraliKrishna et al., 1998). Cell sorting was performed by using a FACS Aria II (BD), and flow cytometry data were collected on a FACS Canto II (BD). FACS data were analyzed by using FlowJo software (TreeStar). 
RNA Isolation and Microarray Analysis
RNA from sorted cells was purified (QIAGEN), linearly amplified (NuGEN), and hybridized to Affymetrix mouse 430 2.0 arrays (Memorial Sloan-Kettering Cancer Center, Genomics Core Facility). Gene pattern 3.4 and the associated modules were used to analyze the microarray data. Gene set enrichment analysis (GSEA) was performed as described previously (Subramanian et al., 2005) .
Genomic DNA Methylation Analysis Bisulfite modification of genomic DNA from FACS purified cells was performed using the Zymo Research EZ DNA methylation kit. Bisulfite modified DNA was PCR amplified with locus-specific primers (Table S2 ) as previously described (Youngblood et al., 2010) .
Statistical Analysis
All experiments were analyzed using Prism 4. Statistically significant p values of <0.05 are indicated and were determined by using a two-tailed unpaired Student's t test.
ACCESSION NUMBERS
The microarray data are available in the Gene Expression Omnibus (GEO) database (http://www.ncbi.nlm.nih.gov/geo) under the accession number GSE43863.
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